ENHATCH

Enhatch operates as a medical technology company, providing what it terms an "Intelligent Surgery Ecosystem" to the orthopedic industry. The firm was co-founded in 2012 by Peter Verrillo, who serves as CEO, and Michael Phipps, the company's President. Both founders, along with other members of the leadership team, bring extensive experience from the orthopedic sector, having worked at companies like Stryker Orthopedics and Tornier and successfully launched global implant systems. This background in medical device development and logistics directly informed the creation of Enhatch's platform.

The company's core offering is a cloud-based, AI-powered platform designed to streamline the entire workflow for patient-specific surgical procedures. It serves medical device manufacturers, from startups to large enterprises, as well as surgeons, distributors, and hospitals. The business model appears to be software-as-a-service (SaaS), providing partners with access to its integrated ecosystem. This platform facilitates preoperative planning by converting medical imaging like CT scans and X-rays into precise 3D anatomical models. Artificial intelligence is utilized to automate and accelerate this process, enabling the rapid design of patient-matched surgical guides and implants.

The platform functions as a centralized portal for surgical case management, allowing surgeons, engineers, and sales representatives to collaborate remotely, share plans, and manage approvals. Key features include a DICOM viewer, customizable workflows that can sync with a client's existing CRM or ERP systems, and a dashboard for tracking case progress. By providing these tools, Enhatch aims to make the adoption of personalized medical devices more efficient and scalable for its clients. The company has established key partnerships, notably with 3D Systems, a prominent additive manufacturing firm, to facilitate the seamless production of its 3D-planned designs. Financially, Enhatch is venture-backed, having raised a total of $15 million over five funding rounds, with its most recent Series A round in June 2021 raising $9 million. Major investors include Trousdale Capital, Apis Holdings, and Numeta Capital.

Keywords: orthopedic surgery, surgical planning, medical technology, patient-specific implants, AI in healthcare, 3D surgical planning, medical device software, surgical workflow automation, digital health, intelligent surgery, preoperative planning, personalized medicine, additive manufacturing, surgical guides, medtech, healthtech, orthopedic logistics, surgical case management, DICOM viewer, venture capital-backed